Amicus Therapeutics Inc (NASDAQ:FOLD) currently has a daily average trading volume of 4.32M but it saw 3856594 shares traded in last market. With a market cap of 1.90B USD, the company’s current market price of $6.17 came rising about 0.49 while comparing to the previous closing price of $6.14. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.65 and as low as $5.81. In the recent trading on the day, stock has struck highest price mark of $6.0 while lowest mark touched by it was $6.19.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Morgan Stanley which downgraded the stock as “Equal-Weight” in its note to investors issued on December 13, 2024, recommending a price target of between $17 and $12 for it. Wells Fargo issued its recommendations for the stock as it initiated the price target for the stock is $18.
Over the week, FOLD’s stock price is moving 3.52% up while it is 2.49% when we observe its performance for the past one month. Year-to-date it is -34.50% down and over the past year, the stock is showing a downside performance of -38.61%.
The company is expected to be releasing its next quarterly report on 2025-Apr-30, for which analysts forecasted an EPS of 0.02 while estimate for next year EPS is 0.33. In next quarter, company is expected to be making quarterly sales of $164.1M as analysts are expecting the sales for current fiscal year at $621.78M and seeing the company making $763.38M in sales next year. Moreover, analysts are in estimates of $147.04M for current-quarter revenue.
Currently, Amicus Therapeutics Inc’s total number of outstanding shares is 307.92M with 0.75% of that held by the insiders while 102.83% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -4.67% and return on equity (ROE) at -18.12%. It has a 23.89 of forward P/E ratio. Stock’s beta reads 0.53. Stock has a price to book (P/B) ratio of 9.82 while price to sale or P/S ratio amounts to 3.50. Its return on asset (ROA) is -3.89% on average.
